Friday, November 7, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Stocks

Vonovia Stock: Strong Recovery Fuels Optimism

Robert Sasse by Robert Sasse
August 6, 2025
in Stocks
0
Vonovia Stock
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

Germany’s largest residential real estate group has reported a robust first-half performance, signaling a turnaround in the property market. Vonovia’s adjusted pre-tax profit surged by 11% to €984 million, while EBITDA rose 12% to €1.42 billion, driven by strong rental growth and strategic sales. The operating free cash flow—critical for dividends—jumped 53% to €1.17 billion, exceeding analyst expectations. Rental income increased 2.6% to €1.69 billion despite a smaller portfolio, with average rents climbing 4.6% to €8.22 per square meter. The vacancy rate dipped to 2.1%, underscoring resilient demand.

Growth Segments Shine

Recurring Sales EBITDA soared 74% to €38.7 million, while the development division swung to a €54 million profit. Value-Add Services nearly doubled EBITDA to €100.7 million. Portfolio valuations rose 1.3%, reflecting market recovery. Vonovia raised its 2025 guidance, targeting adjusted pre-tax profit of €1.85–1.95 billion, up from €1.75–1.85 billion, and confirmed plans to double investments to €2 billion by 2028. Strategic deals, including a €700 million Berlin land transaction, strengthened its balance sheet, with debt easing to 47.3%. The upbeat results suggest sustained momentum ahead.

Ad

Vonovia Stock: Buy or Sell?! New Vonovia Analysis from November 7 delivers the answer:

The latest Vonovia figures speak for themselves: Urgent action needed for Vonovia investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 7.

Vonovia: Buy or sell? Read more here...

Tags: Vonovia
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Royal Gold Stock
Stocks

Royal Gold Shares Surge to Record High on Acquisition Momentum

September 29, 2025
Unitedhealth Stock
Stocks

UnitedHealth Shares Present Conflicting Outlook for Investors

September 29, 2025
ASML Stock
Stocks

ASML Forges Strategic AI Alliance to Bolster Semiconductor Dominance

September 29, 2025
Next Post
ABN Amro Stock

ABN Amro Stock: Profit Dip Amid Strong Capital Moves

Beiersdorf Stock

Beiersdorf Stock: Nivea's Glow Fades as Forecasts Dim

Fresenius Stock

Fresenius Stock: Mixed Q2 Results Amid Margin Pressures

Recommended

Amazon Stock

Amazon’s AI Strategy: Empowering Sellers to Drive Marketplace Growth

2 months ago
Biotechnology Market Capitalization

Calidi Biotherapeutics Unveils Revolutionary Systemic Enveloped Oncolytic Virotherapy Platform

2 years ago
ES stock news

abrdn plc Reduces Stake in Eversource Energy: An Analysis of Financial Indicators and Considerations for Investors.

2 years ago
Micron Stock

Micron Capitalizes on AI Demand with Sold-Out HBM Production

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Leadership Shakeup at Lantheus Amid Strong Quarterly Performance

FedEx Sets Stage for Major Freight Division Spinoff

Sensei Biotherapeutics Faces Existential Crisis After Halting Lead Candidate

Analysts Rally Behind Halliburton Shares Amid Market Recovery

Iovance Shares Surge on Stronger-Than-Expected Earnings Performance

Cava Shares Continue Downward Spiral Following Disappointing Earnings

Trending

Dillard's Stock
Analysis

Dillard’s Faces Critical Earnings Test Amid Divergent Analyst Views

by Felix Baarz
November 7, 2025
0

Investors in Dillard's are bracing for a pivotal moment as the department store chain prepares to release...

Cellectar Stock

Cellectar Shares Gain as Key Catalysts Approach

November 7, 2025
Core Scientific Stock

Core Scientific’s Strategic Pivot Gains Momentum Amid Legal Resolution

November 7, 2025
Lantheus Stock

Leadership Shakeup at Lantheus Amid Strong Quarterly Performance

November 7, 2025
FedEx Stock

FedEx Sets Stage for Major Freight Division Spinoff

November 7, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Dillard’s Faces Critical Earnings Test Amid Divergent Analyst Views
  • Cellectar Shares Gain as Key Catalysts Approach
  • Core Scientific’s Strategic Pivot Gains Momentum Amid Legal Resolution

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com